Literature DB >> 16998770

The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.

Susan E Reef1, Stephen L Cochi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16998770     DOI： 10.1086/505943

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  16 in total

1.  Emergence and continuous evolution of genotype 1E rubella viruses in China.

Authors:  Zhen Zhu; Aili Cui; Huanhuan Wang; Yan Zhang; Chunyu Liu; Changyin Wang; Shujie Zhou; Xia Chen; Zhenying Zhang; Daxin Feng; Yan Wang; Haiyun Chen; Zhengfan Pan; Xiangjie Zeng; Jianhui Zhou; Shuang Wang; Xin Chang; Yue Lei; Hong Tian; Yang Liu; Shunde Zhou; Jun Zhan; Hui Chen; Suyi Gu; Xiaoling Tian; Jianfeng Liu; Ying Chen; Hong Fu; Xiuhui Yang; Huanying Zheng; Leng Liu; Lei Zheng; Hui Gao; Jilan He; Li Sun; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27/3 in junior high school.

Authors:  Ching-Chiang Lin; Chun-Yuh Yang; Yung-Luen Shih; Yang-Yang Huang; Tsung-Han Yang; Jin-Yuan Liang; Chu-Fen Chang; Hsiu-Shu Hsieh; Yeou-Lih Huang
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

3.  Protecting vulnerable populations from pandemic influenza in the United States: a strategic imperative.

Authors:  Sonja S Hutchins; Benedict I Truman; Toby L Merlin; Stephen C Redd
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

Review 4.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

5.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

6.  Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children.

Authors:  Shelly D Senders; Nickoya D Bundick; Jianing Li; Carol Zecca; Frans A Helmond
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

7.  Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.

Authors:  Rohan Ameratunga; Chun-Jen J Chen; Wikke Koopmans; P Rod Dunbar; Maia Brewerton; Richard Lloydd; Claudia J Mansell; Chris van Vliet; See-Tarn Woon
Journal:  J Clin Immunol       Date:  2014-08-12       Impact factor: 8.317

8.  Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Krista M Goergen; Diane E Grill; Min-Hsin Chen; Lijuan Hao; Joseph Icenogle; Gregory A Poland
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

9.  A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.

Authors:  Gary S Marshall; Shelly D Senders; Julie Shepard; Jerry D Twiggs; Julie Gardner; Darcy Hille; Jonathan Hartzel; Rowan Valenzuela; Jon E Stek; Frans A Helmond
Journal:  Hum Vaccin Immunother       Date:  2016-05-05       Impact factor: 3.452

Review 10.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.